The document discusses the Implantable Miniature Telescope (IMT), an FDA approved implant for patients over 75 with macular degeneration. The IMT requires patients to undergo training and show a five letter improvement on an eye chart with an external telescope. The FDA created detailed labeling and agreements patients must complete acknowledging risks. While the IMT has potential to improve vision, there are risks like corneal endothelial cell loss and some patients required explantation. Patients undergo a 3 month rehabilitation program after the 35 minute surgery.

1. Implantable Miniature Telescope (IMT)